Heart Test Laboratories GAAP EPS of -2.27 beats by 0.21
| RDY Stock | USD 14.48 0.21 1.43% |
Slightly above 55% of Dr Reddys' investor base is interested to short. The analysis of overall sentiment of trading Dr Reddys Laboratories stock suggests that many investors are impartial at this time. Dr Reddys' investing sentiment can be driven by a variety of factors including economic data, Dr Reddys' earnings reports, geopolitical events, and overall market trends.
RDY |
Heart Test Laboratories beats Q2 earnings expectations with a GAAP EPS of -2.27, leading to a 5.71 percent increase in shares.
Read at seekingalpha.com
 |
Dr Reddys Laboratories Current Investor Sentiment
Panic Vs Confidence
45
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Dr Reddys' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Dr Reddys Laboratories.
News SentimentBullish | Hype SentimentBearish | Insider SentimentWaiting |
Dr Reddys Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Dr Reddys can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Dr Reddys Fundamental Analysis
We analyze Dr Reddys' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dr Reddys using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dr Reddys based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Dr Reddys is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Dr Reddys Laboratories Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dr Reddys stock to make a market-neutral strategy. Peer analysis of Dr Reddys could also be used in its relative valuation, which is a method of valuing Dr Reddys by comparing valuation metrics with similar companies.
Peers
Dr Reddys Related Equities
| EVO | Evotec SE | 2.36 | ||||
| ITCI | Intracellular | 2.17 | ||||
| COLL | Collegium Pharmaceutical | 0.59 | ||||
| ALKS | Alkermes Plc | 0.26 | ||||
| PCRX | Pacira BioSciences, | 0.20 | ||||
| SUPN | Supernus Pharmaceuticals | 0.74 | ||||
| ANIP | ANI Pharmaceuticals | 0.94 | ||||
| PAHC | Phibro Animal | 1.33 | ||||
| PBH | Prestige Brand | 1.95 |
Additional Tools for RDY Stock Analysis
When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.